Our free fortnightly PML webinars continue with the ninth session on Thursday (16th February) at 16:00 CET, 15:00 GMT, 1000 EST;
Dan Weiner will give a lecture on allometric scaling, where he will demonstrate how to simultaneously fit an allometric model to data from mouse, rat and man. If you have not registered for this webinar, please visit our website: https://www.certara.com/software/pkpd-modeling-and-simulation/pml-school/ We have a wide variety of topics covered over the next few months including just before the PAGE meeting; Advanced Pharmacometrics PK/PD Modeling Course using Phoenix NLME http://www.certarauniversity.com/lms/index.php?r=course/details&id=37 Sign up now to make the mode of early-bird and multiple registration discounts. Intro to Phoenix WinNonlin, 22-24 Feb 2017, Barcelona, Spain Intermediate PKPD with Phoenix (Mon-Thur) 3-6 April, Copenhagen, Denmark Intro to Phoenix WinNonlin, 25-27 Apr (Tue-Thur) 2017, Basel, Switzerland Intro to Phoenix NLME (Thur-Fri) 27-28 Apr 2017 Basel, Switzerland Intermediate Population Modeling Methodology using Phoenix NLME 16-17 May 2017, Paris, France Advanced Pharmacometrics PK/PD Modeling Course using Phoenix NLME 18-19 May 2017, Paris, France PAGE Workshop - Advanced NLME 5-6 June 2017, Budapest, Hungary Intermediate Population Modeling Methodology using Phoenix NLME 10-11 Jul 2017, Crete, Greece Intro to Phoenix WinNonlin, 19-21 Sep 2017, Amsterdam, Netherlands Intro to Phoenix WinNonlin, 7-9Nov 2017, London, UK Intro to Phoenix NLME (Tue-Wed) 9-10 Nov, London, UK If you’re not based in Europe then please look at the full range of courses available at http://www.certarauniversity.com/lms/ which also includes the option of taking courses online. Lastly to keep up to date with Certara’s product and training offering please *follow* this post on the forum; https://support.certara.com/forums/topic/654-forthcoming-training-dates/ Simon DAVIS Senior Scientific Consultant simon.da...@certara.com<mailto:simon.da...@certara.com> NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
